(EMXC) Amundi MSCI Emerging Ex - Ratings and Ratios
Exchange: XETRA • Country: Germany • Currency: EUR • Type: Etf • ISIN: LU2009202107 • Global Emerging Markets Equity
EMXC: Stocks, Bonds, Emerging Markets, China Excluded, Investment Fund
Amundi MSCI Emerging Ex China UCITS ETF Acc (Ticker: EMXC), listed on XETRA, is a Germany-domiciled ETF designed to provide exposure to emerging markets equities while excluding China. With an AUM of 939.53M EUR, it is a sizeable fund that offers diversification across a broad range of emerging economies.
The fund tracks the Morningstar EM TME NR USD Index, which focuses on emerging markets excluding China. This exclusion is notable for investors seeking to reduce exposure to China-specific risks, such as geopolitical tensions or regulatory changes. The ETF’s tracking error has historically been tight, typically ranging between 2-3%, indicating strong alignment with its underlying index.
From a cost perspective, EMXC has an expense ratio of 0.18%, which is competitive within the emerging markets ETF space. Its annual turnover ratio typically falls between 30-40%, suggesting a relatively stable portfolio with limited churn. This can be beneficial for long-term investors aiming to minimize trading costs.
The ETF holds approximately 600 securities, providing broad diversification across emerging markets. Geographically, the portfolio is weighted toward Asia (excluding China), Latin America, EMEA (Europe, Middle East, and Africa), and Emerging Europe. Sector-wise, it is heavily allocated to Information Technology, Financials, Consumer Discretionary, and Communication Services. Notably, the fund avoids concentration risk, with its top 10 holdings each representing less than 5% of the portfolio.
For investors, EMXC offers a UCITS-compliant structure, which ensures adherence to European regulatory standards. It is listed on XETRA, making it accessible to European investors. The absence of P/E, P/B, and other valuation metrics in the provided data suggests that the fund’s strategy is more focused on index tracking rather than seeking to capitalize on specific valuation opportunities.
Additional Sources for EMXC ETF
EMXC ETF Overview
Market Cap in USD | 1,019m |
Category | Global Emerging Markets Equity |
TER | 0.15% |
IPO / Inception | 2019-06-19 |
EMXC ETF Ratings
Growth 5y | 63.4% |
Fundamental | - |
Dividend | 0.0% |
Rel. Strength Industry | -21.1 |
Analysts | - |
Fair Price Momentum | 22.50 EUR |
Fair Price DCF | - |
EMXC Dividends
No Dividends PaidEMXC Growth Ratios
Growth Correlation 3m | -39.9% |
Growth Correlation 12m | 45.6% |
Growth Correlation 5y | 70.2% |
CAGR 5y | 12.19% |
CAGR/Max DD 5y | 0.70 |
Sharpe Ratio 12m | 0.05 |
Alpha | -8.37 |
Beta | 0.69 |
Volatility | 15.59% |
Current Volume | 36.9k |
Average Volume 20d | 39.8k |
As of March 14, 2025, the stock is trading at EUR 23.34 with a total of 36,949 shares traded.
Over the past week, the price has changed by -2.22%, over one month by -8.00%, over three months by -8.88% and over the past year by -1.54%.
Yes. Based on ValueRay Analyses, Amundi MSCI Emerging Ex (XETRA:EMXC) is currently (March 2025) a good stock to buy. It has a ValueRay Growth Rating of 63.44 and therefor a clear technical positive rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of EMXC as of March 2025 is 22.50. This means that EMXC is currently overvalued and has a potential downside of -3.6%.
Amundi MSCI Emerging Ex has no consensus analysts rating.
According to ValueRays Forecast Model, EMXC Amundi MSCI Emerging Ex will be worth about 25 in March 2026. The stock is currently trading at 23.34. This means that the stock has a potential upside of +7.07%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 25 | 7.1% |